The Limitless Stack: Why Researchers Are Stacking NAD+, Selank, and Semax Together

Three Pathways. One Protocol.

In the world of peptide research, compounds rarely work in isolation. The most interesting findings in recent years have come from investigators exploring how multiple peptides with complementary mechanisms can be studied together.

The Limitless Stack — Popular Peptides' bundle of NAD+ Nasal Spray, Selank Nasal Spray, and Semax Nasal Spray — brings together three of the most studied cognitive and cellular recovery compounds in a single convenient order.

Here's what makes each compound interesting, and why researchers are increasingly studying them in combination.

NAD+: The Cellular Energy Currency

NAD+ (Nicotinamide Adenine Dinucleotide) is arguably the most important coenzyme in cellular biology. It participates in hundreds of metabolic reactions, acts as the primary substrate for sirtuin enzymes, and plays a central role in DNA repair pathways.

Research has consistently shown that NAD+ levels decline with age — dropping by as much as 50% between the ages of 40 and 60. This decline has been associated with reduced mitochondrial efficiency, impaired DNA repair, and decreased sirtuin activity.

The nasal spray delivery format is of particular research interest because of the potential for direct access to central nervous system tissue via the olfactory pathway — a route that bypasses hepatic first-pass metabolism.

Selank: Anxiolytic Research Without Sedation

Selank is a synthetic heptapeptide analogue of tuftsin developed in Russia in the 1990s. It has been studied in both preclinical and clinical settings for its anxiolytic and nootropic properties.

What makes Selank particularly interesting to researchers is its selectivity profile. Unlike classical anxiolytic compounds, Selank appears to modulate GABA activity without causing sedation in preclinical models. Studies have also examined its effects on serotonin metabolism, BDNF expression, and stress hormone regulation.

The nasal spray format allows researchers to explore intranasal administration — a delivery route with significant implications for compounds that interact with central nervous system receptors.

Semax: Neuroprotection and BDNF Research

Semax is derived from the N-terminal fragment of ACTH (adrenocorticotropic hormone) and is one of the most extensively studied neuroprotective peptides in the scientific literature. Originally developed at the Institute of Molecular Genetics in Moscow, it has been the subject of hundreds of published studies.

Research on Semax has focused on its ability to upregulate BDNF (Brain-Derived Neurotrophic Factor), its neuroprotective effects under ischemic conditions, and its potential to enhance memory consolidation and attention. Some studies have investigated its interactions with the dopaminergic system.

Nasal administration is the primary research route for Semax, making the nasal spray format directly aligned with the established research literature.

Why Researchers Are Studying These Together

The combination of NAD+, Selank, and Semax covers three distinct but complementary research areas:

• —**Cellular energy and longevity** (NAD+)
• —**Stress response and anxiety pathways** (Selank)
• —**Neuroprotection and cognitive function** (Semax)

Researchers studying the intersection of metabolic health, cognitive aging, and stress resilience have a compelling rationale for exploring all three pathways simultaneously. The nasal spray format provides a consistent and convenient delivery method across all three compounds.

The Bundle Advantage

Ordering the Limitless Stack versus purchasing NAD+, Selank, and Semax individually saves on both cost and logistics. A single shipment, a single set of COAs, and a streamlined research setup.

Popular Peptides supplies all three compounds at ≥99% purity with independent third-party testing documentation.

**Disclaimer**: All compounds are for laboratory and research use only. Not approved by Health Canada for therapeutic use.